Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: 24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG [Phase 4]
Phase 4 trial update comparing 24-hour intraocular pressure with travoprost/timolol versus latanoprost/timolol in glaucoma.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Open Label Extension of LipoLat-CS202
Open-label extension study update for LipoLat-CS202 completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Tafluprost Preservative Free Switch Study [Phase 4]
Phase 4 trial update on a tafluprost preservative-free switch study for glaucoma patients.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial [Phase 4]
Phase 4 randomized trial comparing BRIDIN-T 0.15% eye drops to ALPHAGAN-P 0.15% eye drops for efficacy and ocular surface disease in glaucom…
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma [Phase 1]
Phase 1 trial evaluating safety and efficacy of rhNGF eye drops vs vehicle in glaucoma completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-11-23FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)
The FDA approved a supplemental application for COSOPT, the dorzolamide hydrochloride and timolol maleate combination, submitted by Thea Pha…
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: Human Optokinetic Contrast Device (HOCD) to Measure Visual Function and Identify Patients With and Without Glaucoma [NA]
Clinical trial update on the HOCD device study for measuring visual function to identify patients with and without glaucoma; status terminat…
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)
A long-term chart review study assessing the performance and safety of the XEN 45 Gel Stent for glaucoma has been completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma [Phase 2]
Phase 2 trial comparing POLAT-001 to latanoprost in ocular hypertension and open-angle glaucoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma [NA]
Clinical trial comparing 180-degree versus 360-degree selective laser trabeculoplasty as initial therapy for glaucoma has completed with res…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: NSAID vs Steroid in Trabeculectomy Wound Management [Phase 4]
Phase 4 clinical trial update comparing NSAID versus steroid in trabeculectomy wound management for glaucoma.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Comparison of Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma [NA]
Clinical trial comparing Ex-PRESS Mini Glaucoma Shunt to trabeculectomy in open-angle glaucoma has completed with posted results.
-
FDA approval · 2020-10-01FDA Approved: ACETAZOLAMIDE EXTENDED-RELEASE — Original Application (Micro Labs Limited)
FDA approved an acetazolamide extended-release product as an original application from Micro Labs Limited.
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting [Phase 4]
Phase 4 real-world study of Rhopressa for reducing elevated intraocular pressure in glaucoma or ocular hypertension completed with posted re…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients [NA]
Clinical trial update on optic nerve head pressure patterns in ocular hypertensive patients who converted to glaucoma versus those remaining…
-
FDA approval · 2020-09-21FDA Approved: PILOCARPINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approves Amneal Pharmaceuticals NY LLC's pilocarpine hydrochloride under an original generic application.
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves [NA]
A completed clinical trial comparing silicone and porous plate Ahmed glaucoma valves; results posted in 2020.
-
FDA approval · 2020-09-08FDA Approved: BIMATOPROST — Original Application (Micro Labs Limited)
FDA approved the original application for BIMATOPROST from Micro Labs Limited, authorizing a generic version of bimatoprost for reducing int…
-
FDA approval · 2020-09-01FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for LATANOPROST submitted by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Improve Glaucoma Medication Adherence [NA]
This clinical trial update reports a completed study focused on improving adherence to glaucoma medications. Results were posted on 2020-08-…
-
FDA approval · 2020-08-12FDA Approved: BIMATOPROST — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for bimatoprost submitted by Sandoz Inc, authorizing an addition/adjustment to the product's app…
-
FDA approval · 2020-08-07FDA Approved: MITOSOL — Supplemental Application (Mobius Therapeutics LLC)
FDA approved a supplemental application for MITOSOL (mitomycin C) from Mobius Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: Ab Interno Gelatin Stent With Mitomycin C Using Targeted Supra-tenon's Placement
A completed clinical trial evaluating an ab interno gelatin stent with mitomycin C using targeted Supra-tenon's placement for glaucoma; resu…
-
CLINICAL_TRIALS trial_result · 2020-07-02Clinical Trial Update: Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma [Phase 2, Phase 3]
Phase 2/3 trial updates on preservative-free tafluprost eye drops for newly diagnosed glaucoma patients have been completed.
-
FDA approval · 2020-06-01FDA Approved: ROCKLATAN — Supplemental Application (Alcon Laboratories, Inc.)
The FDA approved a supplemental application for ROCKLATAN (netarsudil and latanoprost ophthalmic solution) submitted by Alcon Laboratories.